These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 17947656)

  • 1. Cognate memory CD4+ T cells generated with dendritic cell priming influence the expansion, trafficking, and differentiation of secondary CD8+ T cells and enhance tumor control.
    Hwang ML; Lukens JR; Bullock TN
    J Immunol; 2007 Nov; 179(9):5829-38. PubMed ID: 17947656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+ T cell-independent maintenance and expansion of memory CD8+ T cells derived from in vitro dendritic cell activation.
    Shi M; Xiang J
    Int Immunol; 2006 Jun; 18(6):887-95. PubMed ID: 16621867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cells.
    Bullock TN; Yagita H
    J Immunol; 2005 Jan; 174(2):710-7. PubMed ID: 15634890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognate CD4 help is essential for the reactivation and expansion of CD8 memory T cells directed against the hematopoietic cell-specific dominant minor histocompatibility antigen, H60.
    Ryu SJ; Jung KM; Yoo HS; Kim TW; Kim S; Chang J; Choi EY
    Blood; 2009 Apr; 113(18):4273-80. PubMed ID: 19139082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct CD4 help provision following interaction of memory CD4 and CD8 T cells with distinct antigen-presenting dendritic cells.
    de Goër de Herve MG; Dembele B; Vallée M; Herr F; Cariou A; Taoufik Y
    J Immunol; 2010 Jul; 185(2):1028-36. PubMed ID: 20562265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-2 is required for the activation of memory CD8+ T cells via antigen cross-presentation.
    Blachère NE; Morris HK; Braun D; Saklani H; Di Santo JP; Darnell RB; Albert ML
    J Immunol; 2006 Jun; 176(12):7288-300. PubMed ID: 16751372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity.
    Smith CM; Wilson NS; Waithman J; Villadangos JA; Carbone FR; Heath WR; Belz GT
    Nat Immunol; 2004 Nov; 5(11):1143-8. PubMed ID: 15475958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DC-induced CD8(+) T-cell response is inhibited by MHC class II-dependent DX5(+)CD4(+) Treg.
    Han WG; Schuurhuis DH; Fu N; Camps M; van Duivenvoorde LM; Louis-Plence P; Franken KL; Huizinga TW; Melief CJ; Toes RE; Ossendorp F
    Eur J Immunol; 2009 Jul; 39(7):1765-73. PubMed ID: 19544486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent roles for CD4+ T cells in the priming and effector/memory phases of adoptive immunotherapy.
    Hu HM; Winter H; Urba WJ; Fox BA
    J Immunol; 2000 Oct; 165(8):4246-53. PubMed ID: 11035058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroma-dependent development of two dendritic-like cell types with distinct antigen presenting capability.
    Periasamy P; O'Neill HC
    Exp Hematol; 2013 Mar; 41(3):281-92. PubMed ID: 23178375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cDC1 prime and are licensed by CD4
    Ferris ST; Durai V; Wu R; Theisen DJ; Ward JP; Bern MD; Davidson JT; Bagadia P; Liu T; Briseño CG; Li L; Gillanders WE; Wu GF; Yokoyama WM; Murphy TL; Schreiber RD; Murphy KM
    Nature; 2020 Aug; 584(7822):624-629. PubMed ID: 32788723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential kinetics of antigen dependency of CD4+ and CD8+ T cells.
    Rabenstein H; Behrendt AC; Ellwart JW; Naumann R; Horsch M; Beckers J; Obst R
    J Immunol; 2014 Apr; 192(8):3507-17. PubMed ID: 24639353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of antigen availability influences the expansion and memory differentiation of T cells.
    Blair DA; Turner DL; Bose TO; Pham QM; Bouchard KR; Williams KJ; McAleer JP; Cauley LS; Vella AT; Lefrançois L
    J Immunol; 2011 Sep; 187(5):2310-21. PubMed ID: 21775679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
    Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
    J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The duration of signaling through CD40 directs biological ability of dendritic cells to induce antitumor immunity.
    Watanabe S; Kagamu H; Yoshizawa H; Fujita N; Tanaka H; Tanaka J; Gejyo F
    J Immunol; 2003 Dec; 171(11):5828-36. PubMed ID: 14634092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell help dependence of memory CD8+ T-cell expansion upon vaccinia virus challenge relies on CD40 signaling.
    Bedenikovic G; Crouse J; Oxenius A
    Eur J Immunol; 2014 Jan; 44(1):115-26. PubMed ID: 24108445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: CD4+ T cell help can be essential for primary CD8+ T cell responses in vivo.
    Wang JC; Livingstone AM
    J Immunol; 2003 Dec; 171(12):6339-43. PubMed ID: 14662830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
    Machy P; Serre K; Baillet M; Leserman L
    J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circumvention of regulatory CD4(+) T cell activity during cross-priming strongly enhances T cell-mediated immunity.
    Heit A; Gebhardt F; Lahl K; Neuenhahn M; Schmitz F; Anderl F; Wagner H; Sparwasser T; Busch DH; Kastenmüller K
    Eur J Immunol; 2008 Jun; 38(6):1585-97. PubMed ID: 18465771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function.
    Doody AD; Kovalchin JT; Mihalyo MA; Hagymasi AT; Drake CG; Adler AJ
    J Immunol; 2004 May; 172(10):6087-92. PubMed ID: 15128793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.